Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 5/20 | 0.60 |
| ▸ | SI | P14410 | 3/20 | 0.60 |
| ▸ | GLB1 | P16278 | 2/20 | 0.41 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | CDA | P32320 | 1/20 | 0.39 |
| ▸ | TREH | O43280 | 1/20 | 0.37 |
| ▸ | AHCY | P23526 | 3/20 | 0.35 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Streptol SCHEMBL16431649 | 0.92 | MGAM (0.64) | MGAMSIGLB1GBA1CDA | |
| SCHEMBL264748 | 0.77 | MGAM (0.58) | MGAMSIGLB1GBA1CDA | |
| Valienamine SCHEMBL14408472 | 0.75 | MGAM (1.00) | MGAMSIGLB1GBA1CDA | |
| SCHEMBL13134512 | 0.75 | MGAM (0.61) | MGAMSIGLB1GBA1CDA | |
| Valienamine SCHEMBL14416123 | 0.75 | MGAM (1.00) | MGAMSIGLB1GBA1CDA | |
| SCHEMBL13922334 | 0.75 | MGAM (0.61) | MGAMSIGLB1GBA1CDA | |
| SCHEMBL14408509 | 0.75 | MGAM (0.61) | MGAMSIGLB1GBA1CDA | |
| Valienamine SCHEMBL352747 | 0.75 | MGAM (1.00) | MGAMSIGLB1GBA1CDA | |
| Valienamine SCHEMBL12955939 | 0.75 | MGAM (1.00) | MGAMSIGLB1GBA1CDA | |
| SCHEMBL14408761 | 0.75 | MGAM (0.61) | MGAMSIGLB1GBA1CDA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| US-20190309289-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2019-10-10 | — | — | US | disclosed |
| US-10370654-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2019-08-06 | — | — | US | disclosed |
| US-20180320170-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2018-11-08 | — | — | US | disclosed |
| US-9944925-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. | 2018-04-17 | — | — | US | disclosed |
| US-20160186168-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2016-06-30 | — | — | US | disclosed |